Author

L. Bonifaz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Cerbulo-Vazquez· 1 shared A. Garcia-Sastre· 1 shared A. Suarez-Martinez· 1 shared A. Tepale-Segura· 1 shared A. Torres-Flores· 1 shared B. Lozano-Dubernard· 1 shared C. Lopez-Macias· 1 shared D. Sarfati-Mizrahi· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Cerbulo-Vazquez

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate AVX/COVID-12 Activates T Cells and Is Recognized by Antibodies from COVID-19 Patients and Vaccinated

A. Torres-Flores, L. A. Ontiveros-Padilla, R. L. Madera-Sandoval, A. Tepale-Segura, J. Gajon-Martinez, T. Rivera-Hernandez, E. A. Ferat-Osorio, A. Cerbulo-Vazquez, L. A. Arriaga-Pizano, L. Bonifaz, G. Paz-De la Rosa, O. Rojas-Martinez, A. Suarez-Martinez, G. Peralta-Sanchez, D. Sarfati-Mizrahi, , C. Lopez-Macias

This paper evaluates the AVX/COVID-12 vaccine's ability to activate T cells and bind antibodies from vaccinated individuals and SARS-CoV-2-infected patients.

bioRxiv · Mar 1, 2024 · PreprintImmunology